
TY  - JOUR
TI  - 2009 Annual Meeting October 18- October 21, 2009
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 29
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.29.10.181e
DO  - doi:10.1592/phco.29.10.181e
SP  - 181e
EP  - 291e
PY  - 2009
ER  - 

TY  - JOUR
TI  - Contributed Podium Presentations
JO  - Value in Health
VL  - 10
IS  - 3
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2007.00197_1.x
DO  - doi:10.1111/j.1524-4733.2007.00197_1.x
SP  - A1
EP  - A21
PY  - 2007
ER  - 

AU  - Galanaud, Jean-Philippe
AU  - Kahn, Susan R.
C7  - pp. 186-196
TI  - Post-thrombotic Syndrome
SN  - 9780470670507
UR  - https://doi.org/10.1002/9781118833391.ch14
DO  - doi:10.1002/9781118833391.ch14
SP  - 186-196
KW  - chronic disease
KW  - compression stockings
KW  - cost-effectiveness
KW  - deep vein thrombosis
KW  - post-thrombotic syndrome
KW  - quality of life
KW  - secondary venous insufficiency
KW  - thrombolysis
KW  - venous thromboembolism
PY  - 2007
AB  - Summary Post-thrombotic syndrome (PTS) is the most frequent complication of deep vein thrombosis (DVT). After a proximal DVT, 20?50% of patients will develop PTS and 5?10% of patients will develop severe PTS, which reduces quality of life and has important socio-economic consequences. A number of risk factors for PTS have been identified; of these, proximal location of DVT and a previous ipsilateral DVT are the most important. PTS is diagnosed on clinical grounds, based on the presence of signs and symptoms of venous insufficiency in the leg ipsilateral to DVT. Therapeutic options for PTS are limited and mainly rely on i) prevention of DVT with use of thromboprophylaxis in high-risk surgical and medical patients; ii) prevention of PTS with compression stockings and, possibly, catheter-directed thrombolysis of iliofemoral DVT if bleeding risk is low; and iii) prevention of DVT recurrence with the use of optimal and/or prolonged duration of anticoagulation.
ER  - 

TY  - JOUR
TI  - 2013 ASPHO abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 60
IS  - S2
SN  - 9780470670507
UR  - https://doi.org/10.1002/pbc.24509
DO  - doi:10.1002/pbc.24509
SP  - S1
EP  - S105
PY  - 2013
ER  - 

TY  - JOUR
TI  - Association of Surgeons of Great Britain and Ireland (Edinburgh 2006) posters
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 93
IS  - S1
SN  - 9780470670507
UR  - https://doi.org/10.1002/bjs.5595
DO  - doi:10.1002/bjs.5595
SP  - 101
EP  - 250
PY  - 2006
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons takes place this year at the Edinburgh International Conference Centre (3rd - 5th May 2006), under the presidency of Mr Denis Wilkins. To view all posters from this meeting, please click the pdf link on this page.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Respirology
VL  - 14
IS  - s3
SN  - 9780470670507
UR  - https://doi.org/10.1111/j.1440-1843.2009.01658.x
DO  - doi:10.1111/j.1440-1843.2009.01658.x
SP  - A170
EP  - A295
PY  - 2009
ER  - 

TY  - JOUR
TI  - RESEARCH POSTER ABSTRACTS
JO  - Value in Health
VL  - 13
IS  - 7
SN  - 9780470670507
UR  - https://doi.org/10.1111/j.1524-4733.2010.00791_2.x
DO  - doi:10.1111/j.1524-4733.2010.00791_2.x
SP  - A250
EP  - A480
PY  - 2010
ER  - 

TY  - JOUR
TI  - Free Communications: Paediatric Malignancy 1
JO  - British Journal of Haematology
VL  - 141
IS  - s1
SN  - 9780470670507
UR  - https://doi.org/10.1111/j.1365-2141.2008.07061.x
DO  - doi:10.1111/j.1365-2141.2008.07061.x
SP  - 1
EP  - 121
PY  - 2008
ER  - 

AU  - del Conde, Ian
AU  - Katzen, Barry T.
C7  - pp. 491-498
TI  - Treatment of Pulmonary Embolism
SN  - 9781118976036
UR  - https://doi.org/10.1002/9781118983652.ch51
DO  - doi:10.1002/9781118983652.ch51
SP  - 491-498
KW  - brain natriuretic peptide
KW  - cardiogenic shock
KW  - chronic thromboembolic pulmonary hypertension
KW  - interventional cardiology
KW  - pulmonary arteries
KW  - pulmonary embolism
KW  - right ventricular failure
KW  - RV dilatation
KW  - RV systolic dysfunction
KW  - surgical embolectomy
PY  - 2008
AB  - Summary Pulmonary embolism (PE) presents in a continuum of severity that spans from incidentally discovered subsegmental PE to massive PE resulting in cardiogenic shock and death. The main cause of death in patients with large PE is right ventricular failure, cardiogenic shock, and refractory hypoxemia. Rapid recanalization of the pulmonary arteries is the ultimate goal of all therapies for acute PE, regardless if pharmacologic, surgical, or catheter-based. All patients presenting with PE should be risk-stratified with the goal of: identifying patients who are at high risk of dying if they do not receive treatment with thrombolysis or surgical embolectomy; and identifying patients who are likely to develop chronic thromboembolic pulmonary hypertension (CTEPH). Normotensive patients with acute PE who have any of the following factors at presentation are at increased risk of death and clinical deterioration: RV systolic dysfunction, RV dilatation, elevated plasma levels of brain natriuretic peptide (BNP) or evidence of myocardial injury.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Nephrology
JA  - Nephrology
VL  - 22
IS  - S3
SN  - 9781118976036
UR  - https://doi.org/10.1111/nep.13105
DO  - doi:10.1111/nep.13105
SP  - 51
EP  - 92
PY  - 2017
ER  - 

TY  - JOUR
TI  - RESEARCH PODIUM ABSTRACTS
JO  - Value in Health
VL  - 13
IS  - 7
SN  - 9781118976036
UR  - https://doi.org/10.1111/j.1524-4733.2010.00791_1.x
DO  - doi:10.1111/j.1524-4733.2010.00791_1.x
SP  - A239
EP  - A250
PY  - 2010
ER  - 

TY  - JOUR
TI  - ISLH Poster Abstracts
JO  - International Journal of Laboratory Hematology
VL  - 30
IS  - s1
SN  - 9781118976036
UR  - https://doi.org/10.1111/j.1751-553X.2008.01062.x
DO  - doi:10.1111/j.1751-553X.2008.01062.x
SP  - 58
EP  - 147
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 9781118976036
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00016.x
DO  - doi:10.1111/j.1538-7836.2007.tb00016.x
SP  - O-M-001
EP  - O-M-096
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts of the 7th Biennial Joanna Briggs Colloquium
JO  - International Journal of Evidence-Based Healthcare
VL  - 8
IS  - 3
SN  - 9781118976036
UR  - https://doi.org/10.1111/j.1744-1609.2010.00179.x
DO  - doi:10.1111/j.1744-1609.2010.00179.x
SP  - 155
EP  - 246
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2018 AANEM Annual Meeting Abstract Guide Washington, DC, October 10â€“13, 2018
JO  - Muscle & Nerve
JA  - Muscle Nerve
VL  - 58
IS  - S2
SN  - 9781118976036
UR  - https://doi.org/10.1002/mus.26353
DO  - doi:10.1002/mus.26353
SP  - S1
EP  - S120
PY  - 2018
ER  - 

TY  - JOUR
TI  - The Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 98
IS  - S7
SN  - 9781118976036
UR  - https://doi.org/10.1002/bjs.7752
DO  - doi:10.1002/bjs.7752
SP  - 1
EP  - 55
PY  - 2011
AB  - Abstract The Annual Scientific Meeting of the Association of Upper Gastrointestinal Surgeons for Great Britain and Ireland takes place this year in Belfast on the 15th and 16th of September. Copyright ? 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Acta Obstetricia et Gynecologica Scandinavica
VL  - 91
IS  - s159
SN  - 9781118976036
UR  - https://doi.org/10.1111/j.1600-0412.2012.01435_2.x
DO  - doi:10.1111/j.1600-0412.2012.01435_2.x
SP  - 59
EP  - 149
PY  - 2012
ER  - 

TY  - JOUR
TI  - Free Paper Abstracts
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 71
IS  - S3
SN  - 9781118976036
UR  - https://doi.org/10.1111/anae.13519
DO  - doi:10.1111/anae.13519
SP  - 7
EP  - 66
PY  - 2016
ER  - 

TY  - JOUR
AU  - Thean, D
AU  - Alberghini, M
TI  - Anticoagulant therapy and its impact on dental patients: a review
JO  - Australian Dental Journal
JA  - Aust Dent J
VL  - 61
IS  - 2
SN  - 9781118976036
UR  - https://doi.org/10.1111/adj.12344
DO  - doi:10.1111/adj.12344
SP  - 149
EP  - 156
KW  - Anticoagulants
KW  - bleeding
KW  - dabigatran
KW  - oral surgery
KW  - rivaroxaban
PY  - 2016
AB  - Abstract Several new oral anticoagulants have been studied in the past decade, and have now started to enter the market. These drugs are reported to be as effective as, or more effective than, warfarin. In Australia, the Therapeutic Goods Administration has approved dabigatran, rivaroxaban and apixaban. The use of these newer anticoagulants is likely to increase in time, and it is important for dentists to have a sound understanding of the mechanisms of action, reversal strategies, and management guidelines for patients taking oral anticoagulants. This article discusses the process of coagulation, available anticoagulants and their monitoring and reversal, and provides clinical advice on the management of patients on anticoagulants who require dental treatment.
ER  - 

TY  - JOUR
TI  - BEST FREE ORALS: BILIARY
JO  - HPB
VL  - 14
IS  - s2
SN  - 9781118976036
UR  - https://doi.org/10.1111/j.1477-2574.2012.00510.x
DO  - doi:10.1111/j.1477-2574.2012.00510.x
SP  - 13
EP  - 106
PY  - 2012
ER  - 
